Mo Aydin is a highly experienced professional in pharmaceutical development, currently serving as the Head of Pharmaceutical Development and Global Head of Inhaled Platform Support at Aspeya since December 2021. Prior roles include Senior Director of Pharmaceutical Development at Theravance Biopharma US, Inc., and Director of Pharmaceutical Development at Insmed Incorporated. Mo has also held key positions at Teva Pharmaceuticals, MicroDose Therapeutx, and Catalent/Cardinal Health/Magellan Labs, showcasing a strong background in respiratory research and development. Mo's academic credentials include a Ph.D. in Inhalation Science from the University of Bath and a B.Sc. (Hons) in Chemical & Pharmaceutical Sciences from the University of Sunderland.
This person is not in any teams
This person is not in any offices